ArticleCVIR endovascular2026

Clinical outcomes of bleomycin electrosclerotherapy (BEST) for the treatment of slow-flow vascular malformations (SFVMs): a UK single-centre experience.

Nicolò Ubaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.